Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23782158

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2013 Jul 4
First author
Byrd JC

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2014 Feb 20;370(8):786
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    N Engl J Med. 2013 Jul 4;369(1):85-7. doi: 10.1056/NEJMe1303054.
    note
    Source null
    related pmid
    23782159
    relationship
    Comment in
  3. citation
    N Engl J Med. 2013 Sep 26;369(13):1278-9. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066758
    relationship
    Comment in
  4. citation
    N Engl J Med. 2013 Sep 26;369(13):1277. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066759
    relationship
    Comment in
  5. citation
    N Engl J Med. 2013 Sep 26;369(13):1277-8. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066760
    relationship
    Comment in
  6. citation
    Expert Rev Hematol. 2013 Oct;6(5):543-6. doi: 10.1586/17474086.2013.831324.
    note
    Source null
    related pmid
    24083545
    relationship
    Comment in

Authors and identifiers

  1. name
    Byrd JC
    type
    Author
  2. name
    Furman RR
    type
    Author
  3. name
    Coutre SE
    type
    Author
  4. name
    Flinn IW
    type
    Author
  5. name
    Burger JA
    type
    Author
  6. name
    Blum KA
    type
    Author
  7. name
    Grant B
    type
    Author
  8. name
    Sharman JP
    type
    Author
  9. name
    Coleman M
    type
    Author
  10. name
    Wierda WG
    type
    Author
  11. name
    Jones JA
    type
    Author
  12. name
    Zhao W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Byrd JC
    type
    Author
  2. name
    Furman RR
    type
    Author
  3. name
    Coutre SE
    type
    Author
  4. name
    Flinn IW
    type
    Author
  5. name
    Burger JA
    type
    Author
  6. name
    Blum KA
    type
    Author
  7. name
    Grant B
    type
    Author
  8. name
    Sharman JP
    type
    Author
  9. name
    Coleman M
    type
    Author
  10. name
    Wierda WG
    type
    Author
  11. name
    Jones JA
    type
    Author
  12. name
    Zhao W
    type
    Author
bibliography ids
  1. nci-bib-bf563dca89158f35e76c7059
book metadata
content sha256
4fbbb2625d020b7d8a86f1b3484981c341368cb431f047b49c11629f5934c711
document type
citation
dois
  1. 10.1056/NEJMoa1215637
electronic publication date
display
2013 Jun 19
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23782158
immutable id
pubmed:23782158@4fbbb2625d020b7d8a86f1b3484981c341368cb431f047b49c11629f5934c711
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
1
name
The New England journal of medicine
nlm unique id
0255562
pages
32-42
volume
369
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2014 Feb 20;370(8):786
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    N Engl J Med. 2013 Jul 4;369(1):85-7. doi: 10.1056/NEJMe1303054.
    note
    Source null
    related pmid
    23782159
    relationship
    Comment in
  3. citation
    N Engl J Med. 2013 Sep 26;369(13):1278-9. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066758
    relationship
    Comment in
  4. citation
    N Engl J Med. 2013 Sep 26;369(13):1277. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066759
    relationship
    Comment in
  5. citation
    N Engl J Med. 2013 Sep 26;369(13):1277-8. doi: 10.1056/NEJMc1309710.
    note
    Source null
    related pmid
    24066760
    relationship
    Comment in
  6. citation
    Expert Rev Hematol. 2013 Oct;6(5):543-6. doi: 10.1586/17474086.2013.831324.
    note
    Source null
    related pmid
    24083545
    relationship
    Comment in
outcomes validated
false
pmid
23782158
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
0e198f89fce73a847cf611193dfdd07405ebcc1409f7edc18081844db51da090
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Jul 4
precision
day
year
2013
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23782158/
title
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

Preserved source evidence · Not medical advice